News

Global Visitors Come To Cullen College Biomedical Engineering Department

By: 

Laurie Fickman
From left, Dr. Lintao Cai, Dr. Guanglin Li, Dr Metin Akay, chair, UH BME department, Dr. Hairong Zheng, Dr Yingchun Zhang, UH BME Department
From left, Dr. Lintao Cai, Dr. Guanglin Li, Dr Metin Akay, chair, UH BME department, Dr. Hairong Zheng, Dr Yingchun Zhang, UH BME Department
From left, Jiten Agarwal, Anupam Ray, Kamala Vanarsa and Dr. Durga Agrawal
From left, Jiten Agarwal, Anupam Ray, Kamala Vanarsa and Dr. Durga Agrawal

The Cullen College department of biomedical engineering hosted a roster of distinguished international guests.

Three representatives of the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Science visited to discuss joint educational and research activities. The visitors included Dr. Lintao Cai, professor and director, SIAT- Institute of Biomedicine and Biotechnology, Dr. Guanglin Li, professor, SIAT- Research Center for Neural Engineering at Institute of Biomedical and Health Engineering and Dr. Hairong Zheng, professor and director of SIAT-Institute of Biomedical and Health Engineering.

On a separate visit, the General Consul of India in Houston, Dr. Anupam Ray, along with UH Regent Dr. Durga Agrawal and Jiten Agarwal, CEO of Expedien Inc., discussed strategies to recruit undergraduate students and build more sustainable research partnerships with research institutes, universities and companies in India.

Department: 

Related News Stories

Class of 2020 honored with virtual graduation celebration

Michelle Gale.

The fortitude of the Cullen College of Engineering's Class of 2020 was proudly celebrated by the university community on May 7, with a 90-minute virtual graduation celebration, featuring remarks from University of Houston leadership, a commencement speaker and most importantly, the graduating students.

Shevkoplyas's Research Seeks New Way to Separate T-Cells

Sergey Shevkoplyas, associate professor of biomedical engineering.

Doors could soon open wider for cell-based therapies, thanks to research underway in the University of Houston lab of Dr. Sergey Shevkoplyas, associate professor of biomedical engineering.

With funding from a Cancer Prevention & Research Institute of Texas grant, Shevkoplyas and his research team are seeking to revolutionize the first step in a patient’s individualized cell-based treatment: the harvesting of T-cells from the patient’s blood.

Upcoming Events / Seminars